ArticleFrontiers in endocrinology2025

Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin.

Anna Maria Cybulska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.